Frontlight ResearchEarly access
Rheumatoid arthritis trials in Israel
2 of 4 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Where
- Jerusalem, Ramat Gan
- Age
- 18 years and over
- People
- 125 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00 - Phase 1Taking peoplePhase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
- Where
- Jerusalem
- Age
- 18 years to 80 years
- People
- 120
- Run by
- Polina Stepensky
See details and how to joinNCT07085676